Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Menichelli

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Frontiers in Cardiovascular Medicine|December 6, 2021
Circulating Lipopolysaccharides and Impaired Antioxidant Status in Patients With Atrial Fibrillation. Data From the ATHERO-AF StudyDanilo Menichelli, Roberto Carnevale, Cristina Nocella, et al.
Internal and Emergency Medicine|July 22, 2018
Hazelnut and cocoa spread improves flow-mediated dilatation in smokersLorenzo Loffredo, Ludovica Perri, Simona Battaglia, et al.
Antioxidants & Redox Signaling|September 1, 2016
Is There an Interplay Between Adherence to Mediterranean Diet, Antioxidant Status, and Vascular Disease in Atrial Fibrillation Patients?Daniele Pastori, Roberto Carnevale, Danilo Menichelli, et al.
Frontiers in Cardiovascular Medicine|November 17, 2025
Neutrophil-lymphocyte ratio and subclinical atherosclerosis in essential hypertensive patientsLuigi Petramala, Francesco Circosta, Leonardo Cremonesi, et al.
Infection|May 3, 2024
Prediction of new-onset atrial fibrillation with the C<sub>2</sub>HEST score in patients admitted with community-acquired pneumoniaDaniele Pastori, Danilo Menichelli, Giulio Francesco Romiti, et al.
Thrombosis Research|May 22, 2026
Matrix metalloproteinase 2 (MMP-2) and cardiovascular events in atrial fibrillation patients: A nested case control study from the ATHERO-AF cohortDanilo Menichelli, Emanuela Falcinelli, Pasquale Pignatelli, et al.
Journal of Thrombosis and Thrombolysis|August 29, 2025
Long-term efficacy and safety of direct oral anticoagulants in venous thrombotic antiphospholipid syndrome patients not candidate to warfarin: A pilot prospective case series studyDaniele Pastori, Danilo Menichelli, Gian Marco Podda, et al.
Journal of the American Heart Association|June 7, 2017
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean DietDaniele Pastori, Roberto Carnevale, Cristina Nocella, et al.
Journal of Thrombosis and Thrombolysis|April 5, 2025
The severity of ischemic stroke and risk of all-cause mortality in patients with atrial fibrillation on different oral anticoagulant treatments admitted to the emergency departmentTommasa Vicario, Danilo Menichelli, Alfredo Paolo Mascolo, et al.
Internal and Emergency Medicine|December 8, 2022
Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysisDaniele Pastori, Danilo Menichelli, Arianna Di Rocco, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Frontiers in Cardiovascular Medicine|December 6, 2021
Circulating Lipopolysaccharides and Impaired Antioxidant Status in Patients With Atrial Fibrillation. Data From the ATHERO-AF StudyDanilo Menichelli, Roberto Carnevale, Cristina Nocella, et al.
Internal and Emergency Medicine|July 22, 2018
Hazelnut and cocoa spread improves flow-mediated dilatation in smokersLorenzo Loffredo, Ludovica Perri, Simona Battaglia, et al.
Antioxidants & Redox Signaling|September 1, 2016
Is There an Interplay Between Adherence to Mediterranean Diet, Antioxidant Status, and Vascular Disease in Atrial Fibrillation Patients?Daniele Pastori, Roberto Carnevale, Danilo Menichelli, et al.
Frontiers in Cardiovascular Medicine|November 17, 2025
Neutrophil-lymphocyte ratio and subclinical atherosclerosis in essential hypertensive patientsLuigi Petramala, Francesco Circosta, Leonardo Cremonesi, et al.
Infection|May 3, 2024
Prediction of new-onset atrial fibrillation with the C<sub>2</sub>HEST score in patients admitted with community-acquired pneumoniaDaniele Pastori, Danilo Menichelli, Giulio Francesco Romiti, et al.
Thrombosis Research|May 22, 2026
Matrix metalloproteinase 2 (MMP-2) and cardiovascular events in atrial fibrillation patients: A nested case control study from the ATHERO-AF cohortDanilo Menichelli, Emanuela Falcinelli, Pasquale Pignatelli, et al.
Journal of Thrombosis and Thrombolysis|August 29, 2025
Long-term efficacy and safety of direct oral anticoagulants in venous thrombotic antiphospholipid syndrome patients not candidate to warfarin: A pilot prospective case series studyDaniele Pastori, Danilo Menichelli, Gian Marco Podda, et al.
Journal of the American Heart Association|June 7, 2017
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean DietDaniele Pastori, Roberto Carnevale, Cristina Nocella, et al.
Journal of Thrombosis and Thrombolysis|April 5, 2025
The severity of ischemic stroke and risk of all-cause mortality in patients with atrial fibrillation on different oral anticoagulant treatments admitted to the emergency departmentTommasa Vicario, Danilo Menichelli, Alfredo Paolo Mascolo, et al.
Internal and Emergency Medicine|December 8, 2022
Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysisDaniele Pastori, Danilo Menichelli, Arianna Di Rocco, et al.
Pageof 10